Frank Field – 2015 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Frank Field on 2015-02-20.

To ask the Secretary of State for Health, what steps he is taking to improve patient care for people with idiopathic pulmonary fibrosis.

Jane Ellison

In 2013, the National Institute for Health and Care Excellence (NICE) published a clinical guideline on idiopathic pulmonary fibrosis (IPF), providing evidence based advice to support clinicians in diagnosing and managing people with IPF which it expects to review in June 2015. Since then, it has published a quality standard for IPF in January 2015. This sets out the markers of high quality in the care of people with IPF and is designed to drive up standards and to reduce inequalities and variation. NICE has also recommended pirfenidone (Esbriet) as a possible treatment for some people with IPF through its technology appraisal programme.

NHS England commissions some services for patients with IPF as part of its specialised services remit. Its respiratory interstitial lung disease (adult) service specification, which includes IPF, sets out what it expects to be in place so that providers can offer evidence based safe and effective services. This specification is currently being updated to ensure it includes the most up to date guidance on IPF including the recently published NICE quality standards. Commissioning of rehabilitation, oxygen services and acute admissions for exacerbations are covered by local commissioning arrangements.